₹297.65
▲ +10.15 +3.53%
05 Aug 2026
NSE Listed · Pharmaceuticals
Influx Healthtech Limited (INFLUX)
Volume: 4,200Avg Vol 1W: 9,720Avg Vol 1M: 18,76452W Range:₹141₹315
Key Ratios
Checked 2h agoMarket Cap—
Current Price₹297.65
Previous Close₹287.5
High / Low (52w)₹315 / ₹141
Volume4,200
Avg Vol (1W)9,720
Avg Vol (1M)18,764
Stock P/E32.13
Book Value₹43.52
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)₹8.87
P/B6.55
Debt / Equity—
50 DMA₹270.54
200 DMA₹234.28
Day change+3.53%
Price Chart
₹297.65▲ 93.34% · 1Y
2025-08-052026-08-05
20-day avg volume: 17K shares
Profit & Loss (Annual)
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹59 Cr | ₹76 Cr | ₹100 Cr | ₹105 Cr |
| EBITDA | ₹0 Cr | ₹6 Cr | ₹10 Cr | ₹15 Cr | ₹18 Cr |
| Net Profit | ₹0 Cr | ₹5 Cr | ₹7 Cr | ₹11 Cr | ₹13 Cr |
| EPS | -1.75 | 1,801.9 | 3.96 | 6.13 | 7.36 |
Balance Sheet
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Total Assets | ₹0 Cr | ₹18 Cr | ₹28 Cr | ₹41 Cr | ₹70 Cr |
| Total Liabilities | ₹0 Cr | ₹13 Cr | ₹17 Cr | ₹18 Cr | ₹34 Cr |
| Equity | ₹0 Cr | ₹5 Cr | ₹12 Cr | ₹23 Cr | ₹36 Cr |
| Total Debt | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹0 Cr | ₹6 Cr | ₹9 Cr | ₹12 Cr | ₹11 Cr |
| Investing | ₹0 Cr | ₹-3 Cr | ₹-5 Cr | ₹-8 Cr | ₹-9 Cr |
| Financing | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr |
| Free Cash Flow | ₹0 Cr | ₹6 Cr | ₹9 Cr | ₹12 Cr | ₹12 Cr |
Efficiency & Working Capital
ROCE59.6%
Interest Coverage1789
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details
As of 2026-03-31
Promoter73.5%
FII0.2%
DII5.6%
Institutions5.8%
Public20.7%
Promoter Pledge0%
No. of Shareholders1,335
Shareholding Pattern
Quarterly — figures in %. Latest 7 quarters.
| Period | Sept 2024 | Oct 2024 | Oct 2024 | Feb 2025 | Jun 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Promoters | 99.9% | 99.9% | 99.9% | 99.9% | 73.5% | 73.5% | 73.5% |
| FIIs | 0% | 0% | 0% | 0% | 3.4% | 1.8% | 0.2% |
| DIIs | 0% | 0.1% | 0% | 0% | 0.3% | 0.1% | 5.6% |
| Public | 0.1% | 0% | 0.1% | 0.1% | 22.8% | 24.6% | 20.7% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 9 | 9 | 9 | 9 | 2,404 | 1,022 | 1,335 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Munir Abdul Ganee Chandniwala | Shareholding of Promoter and Promoter Group | 69.7% | 1.61 Cr |
| Shirin Munir Ahmed Chandniwala | Shareholding of Promoter and Promoter Group | 3.8% | 8,80,638 |
| Kulbhushan Parashar | Public Shareholding | 1.9% | 4,32,000 |
| Ccv Emerging Opportunities Fund-i | Public Shareholding | 1.9% | 4,27,200 |
| Aarth Aif Growth Fund | Public Shareholding | 1.4% | 3,23,400 |
| Finavenue Capital Trust - Finavenue Growth Fund | Public Shareholding | 1.4% | 3,11,400 |
| Abdul Ganee Abdul Rasul Chandniwala | Shareholding of Promoter and Promoter Group | 0% | 726 |
| Ziyaan Munir Chandniwala | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shifaan Munir Chandniwala | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Abdulrauf Ahemadjibhai Sheth | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Suffiyabibi A Rauf Sheth | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shakilahemad Abdulrauf Sheth | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shabanabegum Z Doi | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Ahmedhusan Hajiaabdul Rasul Chandniwala | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Taherabibi A Maja | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Mohmadjamal Abdulnabi Sabugar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Haradwala Sufaiyabibi S | Shareholding of Promoter and Promoter Group | 0% | 0 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Munir Abdul Ganee Chandniwala | Chairman & Managing Director | 2025 |
| Shirin Munir Ahmed Chandniwala | Whole Time Director | 2025 |
| Abdul Ganee Abdul Rasul Chandniwala | Non Executive Director | 2025 |
| ASHOK KUMAR JAIN | Independent Director | 2025 |
| Vipul Balubhai Patel | Independent Director | 2025 |
| Atul Kumar Ashok Kumar Shukla | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Multiple Business | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 25 | 18 | 18 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 3 | 2 | 5 |
| 2025 | 0 | 0 | 0 | 1 | 0 | 1 |
| 2025 | 0 | 0 | 0 | 2 | 2 | 4 |
Company Information
Incorporated2020
ChairmanMunir Abdul Ganee Chandniwala
AuditorV B Goel & Co
Investor Email[email protected]
📍 109 Ghanshyam Enclave Premises, Co-Op Soc Plat #.856 Laljipada, Mumbai, Maharashtra, 400067
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search